Viewing Study NCT02682693


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-07 @ 3:09 PM
Study NCT ID: NCT02682693
Status: COMPLETED
Last Update Posted: 2021-02-02
First Post: 2016-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Denosumab as an add-on Neoadjuvant Treatment (GeparX)
Sponsor: GBG Forschungs GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module